2024 Q3 Form 10-K Financial Statement

#000121390024057975 Filed on July 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2024
Revenue $1.021M $919.4K $6.366M
YoY Change -12.29% 461.81%
Cost Of Revenue $154.8K $546.3K $3.913M
YoY Change -78.31% 445.9%
Gross Profit $865.9K $373.2K $2.453M
YoY Change 92.38% 489.2%
Gross Profit Margin 84.83% 40.59% 38.54%
Selling, General & Admin $273.8K $174.0K $652.8K
YoY Change 120.91% 74.49%
% of Gross Profit 31.62% 46.63% 26.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.80K $10.76K $35.62K
YoY Change 0.0% 341.14%
% of Gross Profit 1.25% 2.88% 1.45%
Operating Expenses $273.8K $174.0K $652.8K
YoY Change 120.91% 74.49%
Operating Profit $592.1K $199.2K $1.801M
YoY Change 81.53% 4161.41%
Interest Expense -$2.300K -$120.00 -$950.00
YoY Change 820.0% -20.83%
% of Operating Profit -0.39% -0.06% -0.05%
Other Income/Expense, Net $16.14K $5.100K $73.01K
YoY Change 626.8% 3078.32%
Pretax Income $608.2K $204.2K $1.874M
YoY Change 85.22% 4105.57%
Income Tax $119.5K $43.02K $309.0K
% Of Pretax Income 19.65% 21.07% 16.49%
Net Earnings $488.7K $161.2K $1.565M
YoY Change 81.94% 3411.87%
Net Earnings / Revenue 47.88% 17.53% 24.58%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.00 $0.01
COMMON SHARES
Basic Shares Outstanding 291.6M shares 29.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.299M $5.158M $5.158M
YoY Change 15.08% 89.8%
Cash & Equivalents $6.299M $5.158M $5.158M
Short-Term Investments
Other Short-Term Assets $269.2K $103.4K $103.4K
YoY Change 1328.72% 448.25%
Inventory
Prepaid Expenses $231.7K $103.4K
Receivables $227.3K $183.6K $183.6K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.795M $5.445M $5.445M
YoY Change 20.81% 79.8% 79.8%
LONG-TERM ASSETS
Property, Plant & Equipment $54.03K $75.33K $271.5K
YoY Change -44.08% 312.62% 189.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $59.58K $59.58K $59.58K
YoY Change -30.98% 114.94%
Total Long-Term Assets $253.9K $331.1K $331.1K
YoY Change -41.3% 172.4% 172.4%
TOTAL ASSETS
Total Short-Term Assets $6.795M $5.445M $5.445M
Total Long-Term Assets $253.9K $331.1K $331.1K
Total Assets $7.049M $5.776M $5.776M
YoY Change 16.37% 83.37% 83.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $624.8K $566.8K $566.8K
YoY Change -55.31% 154.45%
Accrued Expenses $82.17K $109.6K $109.6K
YoY Change -26.52% 272.78%
Deferred Revenue
YoY Change
Short-Term Debt $1.412M $1.283M $1.283M
YoY Change 21.0% 22.55%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.634M $2.269M $2.269M
YoY Change -9.07% 74.61% 74.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $49.13K $89.73K $89.73K
YoY Change -65.45% 102.05%
Total Long-Term Liabilities $49.13K $89.73K $89.73K
YoY Change -65.45% 102.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.634M $2.269M $2.269M
Total Long-Term Liabilities $49.13K $89.73K $89.73K
Total Liabilities $2.683M $2.358M $2.358M
YoY Change -11.71% 75.52% 75.52%
SHAREHOLDERS EQUITY
Retained Earnings -$7.478M -$8.426M
YoY Change -14.82% -15.66%
Common Stock $3.519K $3.519K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $60.40K $60.40K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $4.366M $3.418M $3.418M
YoY Change
Total Liabilities & Shareholders Equity $7.049M $5.776M $5.776M
YoY Change 16.37% 83.37% 83.37%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2024
OPERATING ACTIVITIES
Net Income $488.7K $161.2K $1.565M
YoY Change 81.94% 3411.87%
Depreciation, Depletion And Amortization $10.80K $10.76K $35.62K
YoY Change 0.0% 341.14%
Cash From Operating Activities $853.7K -$1.230M $2.208M
YoY Change 3.2% 18591.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $92.69K
YoY Change 429.58%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$7.550K
YoY Change
Cash From Investing Activities $0.00 -$100.2K
YoY Change 472.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 65.33K $332.9K
YoY Change -100.0% -87.45%
NET CHANGE
Cash From Operating Activities 853.7K -1.230M $2.208M
Cash From Investing Activities 0.000 -$100.2K
Cash From Financing Activities 0.000 65.33K $332.9K
Net Change In Cash 853.7K -1.165M $2.440M
YoY Change -0.31% -7.84%
FREE CASH FLOW
Cash From Operating Activities $853.7K -$1.230M $2.208M
Capital Expenditures $0.00 $92.69K
Free Cash Flow -$1.230M $2.115M
YoY Change -37276.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Entity Registrant Name
EntityRegistrantName
QDM International Inc.
CY2024Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2023 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-27251
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3564984
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 1030B
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
10/F, Ocean Centre, Harbour City
CY2024 dei Entity Address Address Line3
EntityAddressAddressLine3
5 Canton Road
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Tsim Sha Tsui
CY2024 dei Entity Address Country
EntityAddressCountry
HK
CY2024 dei City Area Code
CityAreaCode
+ 852
CY2024 dei Local Phone Number
LocalPhoneNumber
34886893
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
54526325 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
291563930 shares
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024 dei Auditor Firm
AuditorFirmId
6413
CY2024 dei Auditor Name
AuditorName
ZH CPA, LLC
CY2024 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5158223 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2717745 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
183612 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
291900 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
103403 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18856 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
5445238 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3028501 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
196141 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
75557 usd
CY2024Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
59583 usd
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
27720 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75327 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18256 usd
CY2024Q1 us-gaap Assets
Assets
5776289 usd
CY2023Q1 us-gaap Assets
Assets
3150034 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
566780 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
222753 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109556 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29393 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
309043 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2268600 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1299254 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89729 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44406 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2358329 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1343660 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
545386 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
545386 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
545386 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
545386 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
54 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
54 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
291563930 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
291563930 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
291559200 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
291559200 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3519 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3519 usd
CY2023Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
48718 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
473 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
473 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
60395 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
60395 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11901231 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11901231 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8426449 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9990987 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1670 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3417960 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1806374 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5776289 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3150034 usd
CY2024 us-gaap Revenues
Revenues
6366154 usd
CY2023 us-gaap Revenues
Revenues
1133146 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3912743 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
716751 usd
CY2024 us-gaap Gross Profit
GrossProfit
2453411 usd
CY2023 us-gaap Gross Profit
GrossProfit
416395 usd
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
652836 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
374142 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
652836 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
374142 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
1800575 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
42253 usd
CY2024 us-gaap Financing Interest Expense
FinancingInterestExpense
951 usd
CY2023 us-gaap Financing Interest Expense
FinancingInterestExpense
1195 usd
CY2024 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
33165 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40792 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3492 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73006 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2297 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1873581 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44550 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309043 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1564538 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44550 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1670 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
337 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1562868 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44887 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-673972 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44550 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
150000 usd
CY2023 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
337 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2339937 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90478 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
36000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1806374 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1564538 usd
CY2024 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1670 usd
CY2024 qdmi Stock Issued During Period Value Offset With Due To Related Party Balance
StockIssuedDuringPeriodValueOffsetWithDueToRelatedPartyBalance
48718 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3417960 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1564538 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
44550 usd
CY2024 us-gaap Depreciation
Depreciation
35622 usd
CY2023 us-gaap Depreciation
Depreciation
8075 usd
CY2024 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
33165 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
36000 usd
CY2024 us-gaap Noncash Contribution Expense
NoncashContributionExpense
4900 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-108288 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
289426 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
84548 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
31862 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
344028 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
208374 usd
CY2024 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
309043 usd
CY2024 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-8807 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
4240 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2208037 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11813 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92693 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17503 usd
CY2024 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
7548 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100241 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17503 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
332886 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
223972 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2339937 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
60478 usd
CY2023 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
150000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
332886 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2653431 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-204 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
346 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2440478 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2648087 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2717745 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69658 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5158223 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2717745 usd
CY2024 qdmi Noncash Offset Of Subscription Receivable With Due To Related Party Balance
NoncashOffsetOfSubscriptionReceivableWithDueToRelatedPartyBalance
48718 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
220975 usd
CY2021Q4 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
5000 eur
CY2021Q4 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
1 usd
CY2023Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33165 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with the U.S. GAAP requires the Company to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The reported amounts of revenues and expenses may be affected by the estimates that management is required to make. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in facts and circumstances may cause the Company to revise its estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The following are some of the areas requiring significant judgments and estimates as of March 31, 2024 and March 31, 2023: discount rate used in calculation of right-of-use assets and lease liability, valuation assumptions in performing asset impairment tests of long-lived assets, etc. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.8 pure
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Certain Risks and Concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and receivables, and other assets. As of March 31, 2024, substantially all of the Company’s cash and cash equivalents were held in major financial institutions located in Hong Kong, which management considers to being of high credit quality.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended March 31, 2024, the largest customer accounted for 97% of the Company’s total revenue. During the year ended March 31, 2023, the largest customer accounted for 91% of the Company’s total revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended March 31, 2024, the three largest supplier (sub-broker) accounted for 52%, 27% and 15% of the Company’s total costs of sale respectively. During the year ended March 31, 2023, the largest supplier (sub-broker) accounted for 93% of the Company’s total costs of sale.</p>
CY2024 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.50 pure
CY2024 qdmi Amount Of Maintain Paidup Share Capital
AmountOfMaintainPaidupShareCapital
500000 hkd
qdmi Amount Of Maintain Paidup Share Capital
AmountOfMaintainPaidupShareCapital
100000 hkd
CY2023Q4 us-gaap Assets Net
AssetsNet
300000 hkd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.081
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2339937 usd
CY2023Q1 qdmi Offering Cost
OfferingCost
90478 usd
CY2023Q1 qdmi Shares Granted
SharesGranted
36000 shares
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
36000 usd
CY2022 qdmi Stockholders Principal
StockholdersPrincipal
25641 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1170000 hkd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1283221 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1047108 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1873581 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44550 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
393452 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9356 usd
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-6727 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-32862 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7560 usd
CY2024 qdmi Income Tax Reconciliation Income Tax Expense Benefit At Loss Carried Forward
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtLossCarriedForward
-50107 usd
CY2023 qdmi Income Tax Reconciliation Income Tax Expense Benefit At Loss Carried Forward
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtLossCarriedForward
37722 usd
CY2024 qdmi Income Tax Reconciliation Income Tax Expense Benefit At Tax Loss Utilized
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtTaxLossUtilized
27575 usd
CY2023 qdmi Income Tax Reconciliation Income Tax Expense Benefit At Tax Loss Utilized
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtTaxLossUtilized
21776 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309043 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
150241 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
106555 usd
CY2024Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2024 us-gaap Operating Lease Expense
OperatingLeaseExpense
121980 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
42172 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
123888 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
88745 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6441 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
219074 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19789 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
199285 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109556 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89729 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2023 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Noncash Contribution Expense
NoncashContributionExpense
usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2023 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2024 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2024 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CY2023 qdmi Noncash Offset Of Subscription Receivable With Due To Related Party Balance
NoncashOffsetOfSubscriptionReceivableWithDueToRelatedPartyBalance
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
usd
CY2024 qdmi Amount Of Maintain Paidup Share Capital
AmountOfMaintainPaidupShareCapital
64103 usd
qdmi Amount Of Maintain Paidup Share Capital
AmountOfMaintainPaidupShareCapital
12821 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
38462 usd
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001094032

Files In Submission

Name View Source Status
0001213900-24-057975-index-headers.html Edgar Link pending
0001213900-24-057975-index.html Edgar Link pending
0001213900-24-057975.txt Edgar Link pending
0001213900-24-057975-xbrl.zip Edgar Link pending
ea0208514-10k_qdminter.htm Edgar Link pending
ea020851401ex21-1_qdminter.htm Edgar Link pending
ea020851401ex31-1_qdminter.htm Edgar Link pending
ea020851401ex31-2_qdminter.htm Edgar Link pending
ea020851401ex32-1_qdminter.htm Edgar Link pending
ea020851401ex32-2_qdminter.htm Edgar Link pending
ea020851401ex4-1_qdminter.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
qdmi-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qdmi-20240331_cal.xml Edgar Link unprocessable
ea0208514-10k_qdminter_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qdmi-20240331_def.xml Edgar Link unprocessable
qdmi-20240331_lab.xml Edgar Link unprocessable
qdmi-20240331_pre.xml Edgar Link unprocessable